ANGIOTECH PHARMACEUTICALS INC - FORM 10-K - EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - March 16, 2011

Attached files

file filename
10-K - FORM 10-K - ANGIOTECH PHARMACEUTICALS INCd10k.htm
EX-21 - LIST OF WORLDWIDE SUBSIDIARIES - ANGIOTECH PHARMACEUTICALS INCdex21.htm
EX-12 - STATEMENT RE COMPUTATION OF RATIOS - ANGIOTECH PHARMACEUTICALS INCdex12.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex311.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - ANGIOTECH PHARMACEUTICALS INCdex231.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ANGIOTECH PHARMACEUTICALS INCdex322.htm
EX-10.30 - EXECUTIVE EMPLOYMENT AGREEMENT - STEVE BRYANT - ANGIOTECH PHARMACEUTICALS INCdex1030.htm

EXHIBIT 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, the Chief Executive Officer of Angiotech Pharmaceuticals, Inc. (the “Company”), hereby certifies that to his knowledge on the date hereof:

(a) The Company’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 16, 2011      

/S/    WILLIAM L. HUNTER         

       

William L. Hunter, M.D.

Chief Executive Officer

ANGIOTECH PHARMACEUTICALS INC Reports